JOURNAL OF BONE AND MINERAL RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=582723, encodeId=bb23582e2397, content=你好，pending Recomadation之后，怎样了，我现在是这个状态，两三个星期了187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, beContent=187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/02/faf119c47470c5a74aca81ad9321cee3.jpg, createdBy=69981958594, createdName=1e12e991m45(暂无匿称), createdTime=Sun Jan 05 00:00:00 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188222, encodeId=2614118822214, content=偏重的研究方向：骨组织研究 经验分享：非常优秀的骨组织期刊，专科邻域的基础研究第一梯队。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Wed Jan 26 09:30:16 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587726, encodeId=aafb58e7262f, content=能问一下什么时候给50美元的投稿费啊？TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, beContent=TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LX4SlKImgKcC6rLpvajZxw&s=100&t=1580559894, createdBy=869a5281635, createdName=twz0206, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578693, encodeId=be705e86932d, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561991, encodeId=f6dd5619919a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：估计是15年IF骤降至5.6之后要求瞬间变严了，这两年稳定在6.2。刚投了一篇，虽然知道可能性不大，但是想听听审稿人的意见，结果直接被Deputy Editor和Associate Editor拒了，没有送审。让转投JBMR Plus。其实挺看好PLUS的，但是估计近期不会有IF的，所以只能放弃了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71511640504, createdName=gtashley8879, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561350, encodeId=ccde561350b6, content=我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, beContent=zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MDaqWMT2rmsjRXYC9sY2FX0yqKOWiacD8oiafPYptltL1olY2oibXlsEV4zOEIVKwZsVLj77KtPTBKOhQ4Q1zmibeg/132, createdBy=7dcc2073260, createdName=1871f09452m, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547597, encodeId=c49f54e59713, content=刚被拒了!现在一区了.哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?哈哈哈88 2017-09-20 18:04:00 发表: 生物信息学方面骨肉瘤的内容符合要求吗?, beContent=哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547443, encodeId=fba954e44372, content=生物信息学方面骨肉瘤的内容符合要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqoqCCafSuHed7dXeVbxxXj85g5nTbo3qILqEGqTbiaTnqicA1YiadLsaPE9hU05H3G5fpMR1ww4nPAA/132, createdBy=67e71969732, createdName=哈哈哈88, createdTime=Wed Sep 20 18:04:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544310, encodeId=d30c544310b9, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833263, encodeId=9cf1833263e9, content=出现这个情况：disclosure page.disclosures must be included at the time the manuscript is initially submitted to thejbmr……不知道能不能送审，还是会直接被打回来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Fri Aug 19 17:51:46 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2020-01-05 1e12e991m45(暂无匿称)

你好，pending Recomadation之后，怎样了，我现在是这个状态，两三个星期了187****8766 2018-09-21 00:00:00 发表:
我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！

187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！

228 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=582723, encodeId=bb23582e2397, content=你好，pending Recomadation之后，怎样了，我现在是这个状态，两三个星期了187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, beContent=187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/02/faf119c47470c5a74aca81ad9321cee3.jpg, createdBy=69981958594, createdName=1e12e991m45(暂无匿称), createdTime=Sun Jan 05 00:00:00 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188222, encodeId=2614118822214, content=偏重的研究方向：骨组织研究 经验分享：非常优秀的骨组织期刊，专科邻域的基础研究第一梯队。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Wed Jan 26 09:30:16 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587726, encodeId=aafb58e7262f, content=能问一下什么时候给50美元的投稿费啊？TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, beContent=TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LX4SlKImgKcC6rLpvajZxw&s=100&t=1580559894, createdBy=869a5281635, createdName=twz0206, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578693, encodeId=be705e86932d, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561991, encodeId=f6dd5619919a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：估计是15年IF骤降至5.6之后要求瞬间变严了，这两年稳定在6.2。刚投了一篇，虽然知道可能性不大，但是想听听审稿人的意见，结果直接被Deputy Editor和Associate Editor拒了，没有送审。让转投JBMR Plus。其实挺看好PLUS的，但是估计近期不会有IF的，所以只能放弃了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71511640504, createdName=gtashley8879, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561350, encodeId=ccde561350b6, content=我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, beContent=zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MDaqWMT2rmsjRXYC9sY2FX0yqKOWiacD8oiafPYptltL1olY2oibXlsEV4zOEIVKwZsVLj77KtPTBKOhQ4Q1zmibeg/132, createdBy=7dcc2073260, createdName=1871f09452m, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547597, encodeId=c49f54e59713, content=刚被拒了!现在一区了.哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?哈哈哈88 2017-09-20 18:04:00 发表: 生物信息学方面骨肉瘤的内容符合要求吗?, beContent=哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547443, encodeId=fba954e44372, content=生物信息学方面骨肉瘤的内容符合要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqoqCCafSuHed7dXeVbxxXj85g5nTbo3qILqEGqTbiaTnqicA1YiadLsaPE9hU05H3G5fpMR1ww4nPAA/132, createdBy=67e71969732, createdName=哈哈哈88, createdTime=Wed Sep 20 18:04:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544310, encodeId=d30c544310b9, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833263, encodeId=9cf1833263e9, content=出现这个情况：disclosure page.disclosures must be included at the time the manuscript is initially submitted to thejbmr……不知道能不能送审，还是会直接被打回来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Fri Aug 19 17:51:46 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2022-01-26 wrc123

偏重的研究方向：骨组织研究
经验分享：非常优秀的骨组织期刊，专科邻域的基础研究第一梯队。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=582723, encodeId=bb23582e2397, content=你好，pending Recomadation之后，怎样了，我现在是这个状态，两三个星期了187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, beContent=187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/02/faf119c47470c5a74aca81ad9321cee3.jpg, createdBy=69981958594, createdName=1e12e991m45(暂无匿称), createdTime=Sun Jan 05 00:00:00 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188222, encodeId=2614118822214, content=偏重的研究方向：骨组织研究 经验分享：非常优秀的骨组织期刊，专科邻域的基础研究第一梯队。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Wed Jan 26 09:30:16 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587726, encodeId=aafb58e7262f, content=能问一下什么时候给50美元的投稿费啊？TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, beContent=TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LX4SlKImgKcC6rLpvajZxw&s=100&t=1580559894, createdBy=869a5281635, createdName=twz0206, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578693, encodeId=be705e86932d, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561991, encodeId=f6dd5619919a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：估计是15年IF骤降至5.6之后要求瞬间变严了，这两年稳定在6.2。刚投了一篇，虽然知道可能性不大，但是想听听审稿人的意见，结果直接被Deputy Editor和Associate Editor拒了，没有送审。让转投JBMR Plus。其实挺看好PLUS的，但是估计近期不会有IF的，所以只能放弃了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71511640504, createdName=gtashley8879, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561350, encodeId=ccde561350b6, content=我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, beContent=zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MDaqWMT2rmsjRXYC9sY2FX0yqKOWiacD8oiafPYptltL1olY2oibXlsEV4zOEIVKwZsVLj77KtPTBKOhQ4Q1zmibeg/132, createdBy=7dcc2073260, createdName=1871f09452m, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547597, encodeId=c49f54e59713, content=刚被拒了!现在一区了.哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?哈哈哈88 2017-09-20 18:04:00 发表: 生物信息学方面骨肉瘤的内容符合要求吗?, beContent=哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547443, encodeId=fba954e44372, content=生物信息学方面骨肉瘤的内容符合要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqoqCCafSuHed7dXeVbxxXj85g5nTbo3qILqEGqTbiaTnqicA1YiadLsaPE9hU05H3G5fpMR1ww4nPAA/132, createdBy=67e71969732, createdName=哈哈哈88, createdTime=Wed Sep 20 18:04:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544310, encodeId=d30c544310b9, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833263, encodeId=9cf1833263e9, content=出现这个情况：disclosure page.disclosures must be included at the time the manuscript is initially submitted to thejbmr……不知道能不能送审，还是会直接被打回来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Fri Aug 19 17:51:46 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2020-03-30 twz0206

能问一下什么时候给50美元的投稿费啊？TWalker 2019-10-31 00:00:00 发表:
9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？

TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？

238 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=582723, encodeId=bb23582e2397, content=你好，pending Recomadation之后，怎样了，我现在是这个状态，两三个星期了187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, beContent=187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/02/faf119c47470c5a74aca81ad9321cee3.jpg, createdBy=69981958594, createdName=1e12e991m45(暂无匿称), createdTime=Sun Jan 05 00:00:00 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188222, encodeId=2614118822214, content=偏重的研究方向：骨组织研究 经验分享：非常优秀的骨组织期刊，专科邻域的基础研究第一梯队。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Wed Jan 26 09:30:16 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587726, encodeId=aafb58e7262f, content=能问一下什么时候给50美元的投稿费啊？TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, beContent=TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LX4SlKImgKcC6rLpvajZxw&s=100&t=1580559894, createdBy=869a5281635, createdName=twz0206, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578693, encodeId=be705e86932d, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561991, encodeId=f6dd5619919a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：估计是15年IF骤降至5.6之后要求瞬间变严了，这两年稳定在6.2。刚投了一篇，虽然知道可能性不大，但是想听听审稿人的意见，结果直接被Deputy Editor和Associate Editor拒了，没有送审。让转投JBMR Plus。其实挺看好PLUS的，但是估计近期不会有IF的，所以只能放弃了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71511640504, createdName=gtashley8879, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561350, encodeId=ccde561350b6, content=我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, beContent=zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MDaqWMT2rmsjRXYC9sY2FX0yqKOWiacD8oiafPYptltL1olY2oibXlsEV4zOEIVKwZsVLj77KtPTBKOhQ4Q1zmibeg/132, createdBy=7dcc2073260, createdName=1871f09452m, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547597, encodeId=c49f54e59713, content=刚被拒了!现在一区了.哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?哈哈哈88 2017-09-20 18:04:00 发表: 生物信息学方面骨肉瘤的内容符合要求吗?, beContent=哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547443, encodeId=fba954e44372, content=生物信息学方面骨肉瘤的内容符合要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqoqCCafSuHed7dXeVbxxXj85g5nTbo3qILqEGqTbiaTnqicA1YiadLsaPE9hU05H3G5fpMR1ww4nPAA/132, createdBy=67e71969732, createdName=哈哈哈88, createdTime=Wed Sep 20 18:04:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544310, encodeId=d30c544310b9, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833263, encodeId=9cf1833263e9, content=出现这个情况：disclosure page.disclosures must be included at the time the manuscript is initially submitted to thejbmr……不知道能不能送审，还是会直接被打回来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Fri Aug 19 17:51:46 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

命中率高不

231 0

[GetPortalCommentsPageByObjectIdResponse(id=582723, encodeId=bb23582e2397, content=你好，pending Recomadation之后，怎样了，我现在是这个状态，两三个星期了187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, beContent=187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/02/faf119c47470c5a74aca81ad9321cee3.jpg, createdBy=69981958594, createdName=1e12e991m45(暂无匿称), createdTime=Sun Jan 05 00:00:00 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188222, encodeId=2614118822214, content=偏重的研究方向：骨组织研究 经验分享：非常优秀的骨组织期刊，专科邻域的基础研究第一梯队。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Wed Jan 26 09:30:16 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587726, encodeId=aafb58e7262f, content=能问一下什么时候给50美元的投稿费啊？TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, beContent=TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LX4SlKImgKcC6rLpvajZxw&s=100&t=1580559894, createdBy=869a5281635, createdName=twz0206, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578693, encodeId=be705e86932d, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561991, encodeId=f6dd5619919a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：估计是15年IF骤降至5.6之后要求瞬间变严了，这两年稳定在6.2。刚投了一篇，虽然知道可能性不大，但是想听听审稿人的意见，结果直接被Deputy Editor和Associate Editor拒了，没有送审。让转投JBMR Plus。其实挺看好PLUS的，但是估计近期不会有IF的，所以只能放弃了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71511640504, createdName=gtashley8879, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561350, encodeId=ccde561350b6, content=我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, beContent=zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MDaqWMT2rmsjRXYC9sY2FX0yqKOWiacD8oiafPYptltL1olY2oibXlsEV4zOEIVKwZsVLj77KtPTBKOhQ4Q1zmibeg/132, createdBy=7dcc2073260, createdName=1871f09452m, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547597, encodeId=c49f54e59713, content=刚被拒了!现在一区了.哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?哈哈哈88 2017-09-20 18:04:00 发表: 生物信息学方面骨肉瘤的内容符合要求吗?, beContent=哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547443, encodeId=fba954e44372, content=生物信息学方面骨肉瘤的内容符合要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqoqCCafSuHed7dXeVbxxXj85g5nTbo3qILqEGqTbiaTnqicA1YiadLsaPE9hU05H3G5fpMR1ww4nPAA/132, createdBy=67e71969732, createdName=哈哈哈88, createdTime=Wed Sep 20 18:04:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544310, encodeId=d30c544310b9, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833263, encodeId=9cf1833263e9, content=出现这个情况：disclosure page.disclosures must be included at the time the manuscript is initially submitted to thejbmr……不知道能不能送审，还是会直接被打回来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Fri Aug 19 17:51:46 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2018-10-15 gtashley8879

审稿速度:1.0 | 投稿命中率:25.0
经验分享：估计是15年IF骤降至5.6之后要求瞬间变严了，这两年稳定在6.2。刚投了一篇，虽然知道可能性不大，但是想听听审稿人的意见，结果直接被Deputy Editor和Associate Editor拒了，没有送审。让转投JBMR Plus。其实挺看好PLUS的，但是估计近期不会有IF的，所以只能放弃了。

315 0

[GetPortalCommentsPageByObjectIdResponse(id=582723, encodeId=bb23582e2397, content=你好，pending Recomadation之后，怎样了，我现在是这个状态，两三个星期了187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, beContent=187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/02/faf119c47470c5a74aca81ad9321cee3.jpg, createdBy=69981958594, createdName=1e12e991m45(暂无匿称), createdTime=Sun Jan 05 00:00:00 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188222, encodeId=2614118822214, content=偏重的研究方向：骨组织研究 经验分享：非常优秀的骨组织期刊，专科邻域的基础研究第一梯队。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Wed Jan 26 09:30:16 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587726, encodeId=aafb58e7262f, content=能问一下什么时候给50美元的投稿费啊？TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, beContent=TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LX4SlKImgKcC6rLpvajZxw&s=100&t=1580559894, createdBy=869a5281635, createdName=twz0206, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578693, encodeId=be705e86932d, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561991, encodeId=f6dd5619919a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：估计是15年IF骤降至5.6之后要求瞬间变严了，这两年稳定在6.2。刚投了一篇，虽然知道可能性不大，但是想听听审稿人的意见，结果直接被Deputy Editor和Associate Editor拒了，没有送审。让转投JBMR Plus。其实挺看好PLUS的，但是估计近期不会有IF的，所以只能放弃了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71511640504, createdName=gtashley8879, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561350, encodeId=ccde561350b6, content=我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, beContent=zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MDaqWMT2rmsjRXYC9sY2FX0yqKOWiacD8oiafPYptltL1olY2oibXlsEV4zOEIVKwZsVLj77KtPTBKOhQ4Q1zmibeg/132, createdBy=7dcc2073260, createdName=1871f09452m, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547597, encodeId=c49f54e59713, content=刚被拒了!现在一区了.哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?哈哈哈88 2017-09-20 18:04:00 发表: 生物信息学方面骨肉瘤的内容符合要求吗?, beContent=哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547443, encodeId=fba954e44372, content=生物信息学方面骨肉瘤的内容符合要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqoqCCafSuHed7dXeVbxxXj85g5nTbo3qILqEGqTbiaTnqicA1YiadLsaPE9hU05H3G5fpMR1ww4nPAA/132, createdBy=67e71969732, createdName=哈哈哈88, createdTime=Wed Sep 20 18:04:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544310, encodeId=d30c544310b9, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833263, encodeId=9cf1833263e9, content=出现这个情况：disclosure page.disclosures must be included at the time the manuscript is initially submitted to thejbmr……不知道能不能送审，还是会直接被打回来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Fri Aug 19 17:51:46 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2018-09-21 1871f09452m

我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！zzzz889978 2015-06-20 09:54:00 发表:
有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点

zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点

363 0

[GetPortalCommentsPageByObjectIdResponse(id=582723, encodeId=bb23582e2397, content=你好，pending Recomadation之后，怎样了，我现在是这个状态，两三个星期了187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, beContent=187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/02/faf119c47470c5a74aca81ad9321cee3.jpg, createdBy=69981958594, createdName=1e12e991m45(暂无匿称), createdTime=Sun Jan 05 00:00:00 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188222, encodeId=2614118822214, content=偏重的研究方向：骨组织研究 经验分享：非常优秀的骨组织期刊，专科邻域的基础研究第一梯队。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Wed Jan 26 09:30:16 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587726, encodeId=aafb58e7262f, content=能问一下什么时候给50美元的投稿费啊？TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, beContent=TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LX4SlKImgKcC6rLpvajZxw&s=100&t=1580559894, createdBy=869a5281635, createdName=twz0206, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578693, encodeId=be705e86932d, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561991, encodeId=f6dd5619919a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：估计是15年IF骤降至5.6之后要求瞬间变严了，这两年稳定在6.2。刚投了一篇，虽然知道可能性不大，但是想听听审稿人的意见，结果直接被Deputy Editor和Associate Editor拒了，没有送审。让转投JBMR Plus。其实挺看好PLUS的，但是估计近期不会有IF的，所以只能放弃了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71511640504, createdName=gtashley8879, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561350, encodeId=ccde561350b6, content=我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, beContent=zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MDaqWMT2rmsjRXYC9sY2FX0yqKOWiacD8oiafPYptltL1olY2oibXlsEV4zOEIVKwZsVLj77KtPTBKOhQ4Q1zmibeg/132, createdBy=7dcc2073260, createdName=1871f09452m, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547597, encodeId=c49f54e59713, content=刚被拒了!现在一区了.哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?哈哈哈88 2017-09-20 18:04:00 发表: 生物信息学方面骨肉瘤的内容符合要求吗?, beContent=哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547443, encodeId=fba954e44372, content=生物信息学方面骨肉瘤的内容符合要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqoqCCafSuHed7dXeVbxxXj85g5nTbo3qILqEGqTbiaTnqicA1YiadLsaPE9hU05H3G5fpMR1ww4nPAA/132, createdBy=67e71969732, createdName=哈哈哈88, createdTime=Wed Sep 20 18:04:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544310, encodeId=d30c544310b9, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833263, encodeId=9cf1833263e9, content=出现这个情况：disclosure page.disclosures must be included at the time the manuscript is initially submitted to thejbmr……不知道能不能送审，还是会直接被打回来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Fri Aug 19 17:51:46 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2017-09-25 txsyzu_32760595

刚被拒了!现在一区了.哈哈哈88 2017-09-20 发表::
生物信息学方面骨肉瘤的内容符合要求吗?哈哈哈88 2017-09-20 18:04:00 发表:
生物信息学方面骨肉瘤的内容符合要求吗?

哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?

468 0

[GetPortalCommentsPageByObjectIdResponse(id=582723, encodeId=bb23582e2397, content=你好，pending Recomadation之后，怎样了，我现在是这个状态，两三个星期了187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, beContent=187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/02/faf119c47470c5a74aca81ad9321cee3.jpg, createdBy=69981958594, createdName=1e12e991m45(暂无匿称), createdTime=Sun Jan 05 00:00:00 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188222, encodeId=2614118822214, content=偏重的研究方向：骨组织研究 经验分享：非常优秀的骨组织期刊，专科邻域的基础研究第一梯队。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Wed Jan 26 09:30:16 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587726, encodeId=aafb58e7262f, content=能问一下什么时候给50美元的投稿费啊？TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, beContent=TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LX4SlKImgKcC6rLpvajZxw&s=100&t=1580559894, createdBy=869a5281635, createdName=twz0206, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578693, encodeId=be705e86932d, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561991, encodeId=f6dd5619919a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：估计是15年IF骤降至5.6之后要求瞬间变严了，这两年稳定在6.2。刚投了一篇，虽然知道可能性不大，但是想听听审稿人的意见，结果直接被Deputy Editor和Associate Editor拒了，没有送审。让转投JBMR Plus。其实挺看好PLUS的，但是估计近期不会有IF的，所以只能放弃了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71511640504, createdName=gtashley8879, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561350, encodeId=ccde561350b6, content=我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, beContent=zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MDaqWMT2rmsjRXYC9sY2FX0yqKOWiacD8oiafPYptltL1olY2oibXlsEV4zOEIVKwZsVLj77KtPTBKOhQ4Q1zmibeg/132, createdBy=7dcc2073260, createdName=1871f09452m, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547597, encodeId=c49f54e59713, content=刚被拒了!现在一区了.哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?哈哈哈88 2017-09-20 18:04:00 发表: 生物信息学方面骨肉瘤的内容符合要求吗?, beContent=哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547443, encodeId=fba954e44372, content=生物信息学方面骨肉瘤的内容符合要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqoqCCafSuHed7dXeVbxxXj85g5nTbo3qILqEGqTbiaTnqicA1YiadLsaPE9hU05H3G5fpMR1ww4nPAA/132, createdBy=67e71969732, createdName=哈哈哈88, createdTime=Wed Sep 20 18:04:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544310, encodeId=d30c544310b9, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833263, encodeId=9cf1833263e9, content=出现这个情况：disclosure page.disclosures must be included at the time the manuscript is initially submitted to thejbmr……不知道能不能送审，还是会直接被打回来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Fri Aug 19 17:51:46 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2017-09-20 哈哈哈88

生物信息学方面骨肉瘤的内容符合要求吗？

352 0

[GetPortalCommentsPageByObjectIdResponse(id=582723, encodeId=bb23582e2397, content=你好，pending Recomadation之后，怎样了，我现在是这个状态，两三个星期了187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, beContent=187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/02/faf119c47470c5a74aca81ad9321cee3.jpg, createdBy=69981958594, createdName=1e12e991m45(暂无匿称), createdTime=Sun Jan 05 00:00:00 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188222, encodeId=2614118822214, content=偏重的研究方向：骨组织研究 经验分享：非常优秀的骨组织期刊，专科邻域的基础研究第一梯队。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Wed Jan 26 09:30:16 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587726, encodeId=aafb58e7262f, content=能问一下什么时候给50美元的投稿费啊？TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, beContent=TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LX4SlKImgKcC6rLpvajZxw&s=100&t=1580559894, createdBy=869a5281635, createdName=twz0206, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578693, encodeId=be705e86932d, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561991, encodeId=f6dd5619919a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：估计是15年IF骤降至5.6之后要求瞬间变严了，这两年稳定在6.2。刚投了一篇，虽然知道可能性不大，但是想听听审稿人的意见，结果直接被Deputy Editor和Associate Editor拒了，没有送审。让转投JBMR Plus。其实挺看好PLUS的，但是估计近期不会有IF的，所以只能放弃了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71511640504, createdName=gtashley8879, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561350, encodeId=ccde561350b6, content=我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, beContent=zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MDaqWMT2rmsjRXYC9sY2FX0yqKOWiacD8oiafPYptltL1olY2oibXlsEV4zOEIVKwZsVLj77KtPTBKOhQ4Q1zmibeg/132, createdBy=7dcc2073260, createdName=1871f09452m, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547597, encodeId=c49f54e59713, content=刚被拒了!现在一区了.哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?哈哈哈88 2017-09-20 18:04:00 发表: 生物信息学方面骨肉瘤的内容符合要求吗?, beContent=哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547443, encodeId=fba954e44372, content=生物信息学方面骨肉瘤的内容符合要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqoqCCafSuHed7dXeVbxxXj85g5nTbo3qILqEGqTbiaTnqicA1YiadLsaPE9hU05H3G5fpMR1ww4nPAA/132, createdBy=67e71969732, createdName=哈哈哈88, createdTime=Wed Sep 20 18:04:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544310, encodeId=d30c544310b9, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833263, encodeId=9cf1833263e9, content=出现这个情况：disclosure page.disclosures must be included at the time the manuscript is initially submitted to thejbmr……不知道能不能送审，还是会直接被打回来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Fri Aug 19 17:51:46 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2017-07-16 13805560183

赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦

403 0

[GetPortalCommentsPageByObjectIdResponse(id=582723, encodeId=bb23582e2397, content=你好，pending Recomadation之后，怎样了，我现在是这个状态，两三个星期了187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, beContent=187****8766 2018-09-21 00:00:00 发表: 我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/02/faf119c47470c5a74aca81ad9321cee3.jpg, createdBy=69981958594, createdName=1e12e991m45(暂无匿称), createdTime=Sun Jan 05 00:00:00 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188222, encodeId=2614118822214, content=偏重的研究方向：骨组织研究 经验分享：非常优秀的骨组织期刊，专科邻域的基础研究第一梯队。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Wed Jan 26 09:30:16 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587726, encodeId=aafb58e7262f, content=能问一下什么时候给50美元的投稿费啊？TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, beContent=TWalker 2019-10-31 00:00:00 发表: 9.16投的，现在还是under review，并且ADE也没有分配，有没有大神给说一下这是什么情况啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LX4SlKImgKcC6rLpvajZxw&s=100&t=1580559894, createdBy=869a5281635, createdName=twz0206, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578693, encodeId=be705e86932d, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561991, encodeId=f6dd5619919a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：估计是15年IF骤降至5.6之后要求瞬间变严了，这两年稳定在6.2。刚投了一篇，虽然知道可能性不大，但是想听听审稿人的意见，结果直接被Deputy Editor和Associate Editor拒了，没有送审。让转投JBMR Plus。其实挺看好PLUS的，但是估计近期不会有IF的，所以只能放弃了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71511640504, createdName=gtashley8879, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561350, encodeId=ccde561350b6, content=我也投了这个杂志，一个多月under review以后现在显示pending recommendations，希望有个好结果！zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, beContent=zzzz889978 2015-06-20 09:54:00 发表: 有没有投过这个期刊的过来人给点经验，我投了20天了，只是分配了ADM,但是ADE一直没有分配，系统持续显示under review，这是表示送外审了嘛？求过来人指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MDaqWMT2rmsjRXYC9sY2FX0yqKOWiacD8oiafPYptltL1olY2oibXlsEV4zOEIVKwZsVLj77KtPTBKOhQ4Q1zmibeg/132, createdBy=7dcc2073260, createdName=1871f09452m, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547597, encodeId=c49f54e59713, content=刚被拒了!现在一区了.哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?哈哈哈88 2017-09-20 18:04:00 发表: 生物信息学方面骨肉瘤的内容符合要求吗?, beContent=哈哈哈88 2017-09-20 发表:: 生物信息学方面骨肉瘤的内容符合要求吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547443, encodeId=fba954e44372, content=生物信息学方面骨肉瘤的内容符合要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqoqCCafSuHed7dXeVbxxXj85g5nTbo3qILqEGqTbiaTnqicA1YiadLsaPE9hU05H3G5fpMR1ww4nPAA/132, createdBy=67e71969732, createdName=哈哈哈88, createdTime=Wed Sep 20 18:04:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544310, encodeId=d30c544310b9, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833263, encodeId=9cf1833263e9, content=出现这个情况：disclosure page.disclosures must be included at the time the manuscript is initially submitted to thejbmr……不知道能不能送审，还是会直接被打回来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Fri Aug 19 17:51:46 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2016-08-19 ms3214948925389860

出现这个情况：disclosure page.disclosures must be included at the time the manuscript is initially submitted to thejbmr……不知道能不能送审，还是会直接被打回来。

122 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务